| Søg service: |
|
Populære byer København K Århus C Roskilde Frederiksberg Odense C Horsens Brøndby Glostrup Aalborg Valby Odder Randers Svendborg Vejle Rødovre Kolding Silkeborg Sønderborg Fredericia Haderslev |
Annoncer:
2600 Glostrup Smedeland 26B
Zealand Pharma A/S kort
Zealand Pharma A/S
Telefon: 43 28 12 00
Websted (zp.dk)
E-mail-adresse: [javascript protected email address]
Annoncer
indikationer, forskning, peptider, peptidinnovation, Bioteknologi, peptidkemi, peptidprodukter, Biotechnology
Tjenesteydelseskategorier
indikationer forskning peptider peptidinnovation Bioteknologi peptidkemi peptidprodukter BiotechnologyRelaterede Services
Annoncer[email protected]
What is diabetes and metabolic disorders?
ZEAL .CO) biotechnology company focused on bringing novel peptide drugs forward in a cost efficient way to meet the needs of patients, caregivers and society and maximize shareholder value… Read more
h2>Team Zealand Sunstone participate in the “Ride to Cure” Zealand Pharma participate in the “Ride to Cure” fundraising bike race, organized by Juvenile Diabetes Research Foundation (
USA , on 20 Oct. to raise awareness of diabetes as a chronic disease and to obtain funding to support research into new and better treatment options for patients with diabetes.
To see more information about the bike race and how to donate money, please click here (only in Danish):
Information og link til donation
Donations – International Credit Cards
h2>Product Pipeline Zealand Pharma has a mature clinical pipeline of innovative peptide drugs, of which most are developed under partnerships. The lead invention is lixisenatide (Lyxumia®) filed for registration in Europe for Type 2 diabetes. Learn more about Zealand Pharma’s Product Pipeline .
style="clear: both"/>
style="clear: both" /> Fast track Legal disclaimer
Updated: 12.03.2012 Zealand Pharma A/S Smedeland 36
2600 Copenhagen, Denmark Tel +45 88 77 36 00
Fax +45 88 77 38 98
[email protected] Docs & downloads Articles of Association Fact sheet Image bank Publications Careers Board of Directors Careers Contact
style="clear: both" />
What is diabetes and metabolic disorders?
ZEAL .CO) biotechnology company focused on bringing novel peptide drugs forward in a cost efficient way to meet the needs of patients, caregivers and society and maximize shareholder value… Read more
h2>Team Zealand Sunstone participate in the “Ride to Cure” Zealand Pharma participate in the “Ride to Cure” fundraising bike race, organized by Juvenile Diabetes Research Foundation (
USA , on 20 Oct. to raise awareness of diabetes as a chronic disease and to obtain funding to support research into new and better treatment options for patients with diabetes.
To see more information about the bike race and how to donate money, please click here (only in Danish):
Information og link til donation
Donations – International Credit Cards
h2>Product Pipeline Zealand Pharma has a mature clinical pipeline of innovative peptide drugs, of which most are developed under partnerships. The lead invention is lixisenatide (Lyxumia®) filed for registration in Europe for Type 2 diabetes. Learn more about Zealand Pharma’s Product Pipeline .
style="clear: both"/>
style="clear: both" /> Fast track Legal disclaimer
Updated: 12.03.2012 Zealand Pharma A/S Smedeland 36
2600 Copenhagen, Denmark Tel +45 88 77 36 00
Fax +45 88 77 38 98
[email protected] Docs & downloads Articles of Association Fact sheet Image bank Publications Careers Board of Directors Careers Contact
style="clear: both" />
Annoncer